Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by gudisgoodon Mar 01, 2019 11:36am
64 Views
Post# 29428984

RE:RE:RE:The Coming Proxy Battle

RE:RE:RE:The Coming Proxy Battle
Benedict16th wrote: Comparing GUD to Palladin is like comparing apples to oranges, Pallading never had the luxury of the cash hoard opportunity like GUD has had for a too long time. 70% of GUD market cap is in cash. It is almost impossible  to find any other listed company with that type of cash to market cap ratio for that long period of time. 
If anybody of you know of any company with 70% of its market cap in cash please let me know. 
GUD raised the money because " thee were looking at over 100 opportunity...... deals"  
Many companies made deals everyday
After 4-5 Years the story does not becomes credible anymore. Ha... yes tomorrow.....tomorrow....
That is why GUD current  stock price speack volume, the investment comunity are not impresssed, all of them cannot be wrong all the time. 


It's better to have cash than to make poor investments. I, for one, like the approach of only investing when it makes sense. Caving in to outside pressure and making bad investments would be horrible for the creating of shareholder value.

The value is in Goodman's disciplined approach. The approach should be different than everyone else's (to get outsized returns, you have to do things differently). 
Bullboard Posts